StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Asia / Africa / Australasia by Quarter

Asia / Africa / Australasia ($M)

QuarterlyAnnual

Novartis Asia / Africa / Australasia: $2,839M in Q3 2026, up 6.5% from a year earlier.

Latest, Q3 2026
2,839
Period ended Sep 30, 2026
Change on a year earlier
+6.5%
2,666 in Q3 2025
History
30 quarters
Since Q2 2019
Sources
26
Documents cited below

Where the Q3 2026 figure comes from

“|| Asia/Africa/Australasia | 2 839 | 2 666 | 6 | 5 | 20 | 19”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAsia / Africa / Australasia ($M)Year on yearSource
Q3 2026Sep 30, 20262,839+6.5%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20263,018+11.2%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 20263,020+8.9%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20252,646+14.4%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20252,666+5.2%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 20252,713+4.6%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 20252,772+7.4%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20242,313+3.7%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20242,534+7.9%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20242,594+7.0%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 20242,580+12.0%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 20232,231+9.7%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20232,349+3.4%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 20232,425-55.6%Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 20232,303-15.7%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 20222,034-81.5%Novartis Form 6-K (0001370368-24-000007) ↗

Breakdown

What makes up asia / Africa / Australasia

Cite this data

StockData. (2026). Novartis Asia / Africa / Australasia ($M), quarterly Q2 2019–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-aaa

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.